Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/161441
Registo completo
Campo DCValorIdioma
dc.creatorAlmeida, P-
dc.creatorFernandes, Â-
dc.creatorAlves, I-
dc.creatorPinho, SS-
dc.date.accessioned2024-09-10T15:54:55Z-
dc.date.available2024-09-10T15:54:55Z-
dc.date.issued2024-
dc.identifier.issn0008-6215-
dc.identifier.urihttps://hdl.handle.net/10216/161441-
dc.description.abstractTrained Immunity is defined as a biological process normally induced by exogenous or endogenous insults that triggers epigenetic and metabolic reprogramming events associated with long-term adaptation of innate immune cells. This trained phenotype confers enhanced responsiveness to subsequent triggers, resulting in an innate immune "memory" effect. Trained Immunity, in the past decade, has revealed important benefits for host defense and homeostasis, but can also induce potentially harmful outcomes associated with chronic inflammatory disorders or autoimmune diseases. Interestingly, evidence suggest that the "trainers" prompting trained immunity are frequently glycans structures. In fact, the exposure of different types of glycans at the surface of pathogens is a key driver of the training phenotype, leading to the reprogramming of innate immune cells through the recognition of those glycan-triggers by a variety of glycan-binding proteins (GBPs) expressed by the immune cells. β-glucan or mannose-enriched structures in Candida albicans are some of the examples that highlight the potential of glycans in trained immunity, both in homeostasis and in disease. In this review, we will discuss the relevance of glycans exposed by pathogens in establishing key immunological hubs with glycan-recognizing receptors expressed in immune cells, highlighting how this glycan-GBP network can impact trained immunity. Finally, we discuss the power of glycans and GBPs as potential targets in trained immunity, envisioning potential therapeutic applications.pt_PT
dc.description.sponsorshipThis work was supported by grants from SSP: co-funded by the European Union (ERC, GlycanSwitch, 101071386). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. The work was also co-funded by EU GlycanTrigger-grant Agreement No: 101093997. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. SSP also acknowledges funding by “2022 LRA Lupus Innovation Award” and by “European Crohn’s and Colitis Organisation (ECCO) Pioneer Award 2021”. SSP also acknowledges the US Department of Defense, US Army Medical Research Acquisition Activity, FY18 Peer Reviewed Medical Research Program Investigator-Initiated Research Award (award number W81XWH1920053). IA acknowledges the Portuguese Foundation for Science and Technology (FCT) for funding (2022.00337. CEECIND), from BIAL Foundation and Portuguese Medical Association (Maria de Sousa Award 2023), from Núcleo de Estudos de Doenças Autoimunes and Portuguese Society of Internal Medicine (NEDAI-SPMI) and from European Society for Clinical Investigation (ESCI Exploratory Research Grant 2024). ÂF acknowledges FCT for funding (2022.01422. PTDC).pt_PT
dc.language.isoengpt_PT
dc.publisherElsevierpt_PT
dc.relationinfo:eu-repo/grantAgreement/EC/HE/ 101071386/EU-
dc.relationinfo:eu-repo/grantAgreement/EC/HE/101093997/EU-
dc.relationinfo:eu-repo/grantAgreement/FCT/Concurso de Projetos de I&D em Todos os Domínios Científicos - 2022/2022.01422.PTDC/PT-
dc.relationinfo:eu-repo/grantAgreement/EC/HE/ 101071386/EU-
dc.relation.ispartofseriesCarbohydrate research, vol. 544:109245pt_PT
dc.rightsopenAccesspt_PT
dc.subjectBCGpt_PT
dc.subjectCandida albicanspt_PT
dc.subjectGlycan-binding proteinspt_PT
dc.subjectGlycanspt_PT
dc.subjectTolerancept_PT
dc.subjectTrained immunitypt_PT
dc.titleGlycans in Trained Immunity: Educators of innate immune memory in homeostasis and diseasept_PT
dc.typeArtigo em Revista Científica Internacionalpt_PT
dc.contributor.uportoInstituto de Investigação e Inovação em Saúdept_PT
dc.identifier.doi10.1016/j.carres.2024.109245-
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0008621524002246?via%3Dihub-
Aparece nas coleções:I3S - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
10.1016-j.carres.2024.109245.pdf3.57 MBAdobe PDFThumbnail
Ver/Abrir


Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.